Luye Pharma Group Ltd has announced its acquirement of the entire issued share capital of Acino AG and Acino Supply AG for a purchase consideration of $268.8m.

The acquisition is expected to be completed in the second half of 2016.

The transaction will allow Luye Pharma to improve its international approach and gain access to boarder therapeutic areas and will help Acino AG to grow in its key market.

China Resources Sanjiu Medical & Pharmaceutical Co. Ltd has announced to acquire Kunming Shenghuo Pharmaceutical for a purchase consideration of $282.67m.

The company will fund the entire costs associated with the acquisitions through its own funds.